Office of the Director; Notice of Meeting, 96021-96022 [2016-31611]

Download as PDF Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices Dated: December 21, 2016. Joanna Bare, Executive Officer, Division of Management Services, Center for Scientific Review, NIH. [FR Doc. 2016–31543 Filed 12–28–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Vaccine Advisory Committee National Vaccine Program Office, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the National Vaccine Advisory Committee (NVAC). The meeting will be open to the public; public comment sessions will be held during the meeting. SUMMARY: The meeting will be held on February 7 and 8, 2017. The meeting times and agenda will be posted on the NVAC Web site at http://www.hhs.gov/ nvpo/nvac/meetings/index.html as soon as they become available. ADDRESSES: Pre-registration is required for members of the public who wish to attend the meeting and who wish to participate in the public comment session. Individuals who wish to attend the meeting and/or participate in the public comment session should register at http://www.hhs.gov/nvpo/nvac/ meetings/index.html. Participants may also register by emailing nvpo@hhs.gov or by calling (202) 690–5566 and providing their name, organization, and email address. U.S. Department of Health and Human Services, Hubert H. Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, DC 20201. The meeting can also be accessed through a live webcast on both days of the meeting. For more information, visit http://www.hhs.gov/nvpo/nvac/ meetings/index.html. FOR FURTHER INFORMATION CONTACT: National Vaccine Program Office, U.S. Department of Health and Human Services, Room 715H, Hubert H. Humphrey Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: (202) 690–5566; email: nvpo@ hhs.gov. asabaliauskas on DSK3SPTVN1PROD with NOTICES DATES: VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 Pursuant to Section 2101 of the Public Health Service Act (42 U.S.C. 300aa–1), the Secretary of Health and Human Services was mandated to establish the National Vaccine Program to achieve optimal prevention of human infectious diseases through immunization and to achieve optimal prevention against adverse reactions to vaccines. The NVAC was established to provide advice and make recommendations to the Director of the National Vaccine Program on matters related to the Program’s responsibilities. The Assistant Secretary for Health serves as Director of the National Vaccine Program. During the February 2017 NVAC meeting, there will be a discussion of the 21st Century Cures Act and vaccines; an update on the recent mumps outbreaks in the US; presentations on Zika virus disease and the status of Zika vaccine development; presentations on vaccine adverse events and insights from personalized medicine; and the NVAC’s Mid-course Review Working Group will present its findings and draft recommendations for deliberation and vote by the Committee. Please note that agenda items are subject to change as priorities dictate. Information on the final meeting agenda will be posted prior to the meeting on the NVAC Web site: http:// www.hhs.gov/nvpo/nvac/index.html. Public attendance at the meeting is limited to the available space. Individuals who plan to attend in person and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the National Vaccine Program Office at the address/phone listed above at least one week prior to the meeting. For those unable to attend in person, a live webcast will be available. More information on registration and accessing the webcast can be found at http://www.hhs.gov/ nvpo/nvac/meetings/index.html. Members of the public will have the opportunity to provide comments at the NVAC meeting during the public comment periods designated on the agenda. Public comments made during the meeting will be limited to three minutes per person to ensure time is allotted for all those wishing to speak. Individuals are also welcome to submit their written comments. Written comments should not exceed three pages in length. Individuals submitting written comments should email their comments to the National Vaccine Program Office (nvpo@hhs.gov) at least five business days prior to the meeting. SUPPLEMENTARY INFORMATION: PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 96021 Dated: December 21, 2016. Bruce Gellin, Designated Federal Officer, National Vaccine Advisory Committee, Deputy Assistant Secretary for Health. [FR Doc. 2016–31530 Filed 12–28–16; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH Clinical Center Research Hospital Board. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The portions of the meeting devoted to the Anonymous Safety Hotline and the laboratories or units and staff involved in the individual reports to the Hotline, staff, as well as discussions regarding non-executive employees holding specific positions in the Clinical Center will be closed to the public in accordance with the provisions set forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as amended. Premature disclosure of the laboratories or units and staff involved in the individual reports could significantly limit the Hotline’s purpose by compromising anonymity. Discussion of specific nonexecutive employees would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: NIH Clinical Center Research Hospital Board. Date: January 13, 2017. Open: 8:30 a.m. to 12:30 p.m. Agenda: Board Chair’s Overview, Remarks from the NIH Director and the New CEO, Clinical Center Focus Groups, Improving the Clinical Center’s Census, Clinical Center Patient and Worker Safety Metrics. Open: 1:30 p.m. to 3:30 p.m. Agenda: IT Infrastructure and Security, Audits of Delayed Reporting—Self-Audit Results and Formal Audit Planning, Facilities Update. Closed: 3:45 p.m. to Adjournment. Agenda: Anonymous Safety Hotline, Clinical Center Employees. E:\FR\FM\29DEN1.SGM 29DEN1 96022 Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Notices Place: Conference Room 6C6, Building 31, National Institutes of Health, Bethesda, MD 20892. Contact Person: Gretchen Wood, Staff Assistant, National Institutes of Health, Office of the Director, One Center Drive, Building 1 Room 126, Bethesda, MD 20892, 301–496–4272, woodgs@od.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Dated: December 23, 2016. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2016–31611 Filed 12–28–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting asabaliauskas on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Microbiology, Infectious Diseases and AIDS Initial Review Group Microbiology and Infectious Diseases Research Committee. Date: January 26–27, 2017. Time: 11:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Frank S. De Silva, Ph.D., Scientific Review Officer, Scientific Review VerDate Sep<11>2014 18:41 Dec 28, 2016 Jkt 241001 Program, Division of Extramural Activities, Room #3E72A, National Institutes of Health/ NIAID, 5601 Fishers Lane, MSC 9834, Bethesda, MD 20892934, (240) 669–5023, fdesilva@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: December 23, 2016. Natasha M. Copeland, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–31568 Filed 12–28–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Initial Review Group; Neuroscience of Aging Review Committee. Date: February 2–3, 2017. Time: 3:00 p.m. to 12:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Jeannette L. Johnson, Ph.D., Deputy Review Branch Chief, National Institutes of Health, National Institute on Aging, Gateway Building, Bethesda, MD 20892, 301–402–7705, johnsonj9@ nia.nih.gov. Name of Committee: National Institute on Aging Initial Review Group; Behavior and Social Science of Aging Review Committee. Date: February 2–3, 2017. Time: 3:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Kimberly Firth, Ph.D., National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Suite PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 2C212, Bethesda, MD 20892, 301–402–7702, kimberly.firth@nih.gov. Name of Committee: National Institute on Aging Initial Review Group; Biological Aging Review Committee. Date: February 2–3, 2017. Time: 4:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Bita Nakhai, Ph.D., Scientific Review Branch, National Institute on Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301–402–7701, nakhaib@nia.nih.gov. Name of Committee: National Institute on Aging Initial Review Group; Clinical Aging Review Committee. Date: February 2–3, 2017. Time: 4:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Alicja L. Markowska, Ph.D., D.Sc., National Institute on Aging, National Institutes of Health, Gateway Building 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–496–9666, markowsa@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: December 22, 2016. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2016–31433 Filed 12–28–16; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; P30 and P50 Revisions for AD Centers. E:\FR\FM\29DEN1.SGM 29DEN1

Agencies

[Federal Register Volume 81, Number 250 (Thursday, December 29, 2016)]
[Notices]
[Pages 96021-96022]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31611]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App), notice is hereby given of a meeting of the NIH 
Clinical Center Research Hospital Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The portions of the meeting devoted to the Anonymous Safety Hotline 
and the laboratories or units and staff involved in the individual 
reports to the Hotline, staff, as well as discussions regarding non-
executive employees holding specific positions in the Clinical Center 
will be closed to the public in accordance with the provisions set 
forth in section 552b(c)(9)(B) and 552b(c)(6), Title 5 U.S.C., as 
amended. Premature disclosure of the laboratories or units and staff 
involved in the individual reports could significantly limit the 
Hotline's purpose by compromising anonymity. Discussion of specific 
non-executive employees would constitute a clearly unwarranted invasion 
of personal privacy.

    Name of Committee: NIH Clinical Center Research Hospital Board.
    Date: January 13, 2017.
    Open: 8:30 a.m. to 12:30 p.m.
    Agenda: Board Chair's Overview, Remarks from the NIH Director 
and the New CEO, Clinical Center Focus Groups, Improving the 
Clinical Center's Census, Clinical Center Patient and Worker Safety 
Metrics.
    Open: 1:30 p.m. to 3:30 p.m.
    Agenda: IT Infrastructure and Security, Audits of Delayed 
Reporting--Self-Audit Results and Formal Audit Planning, Facilities 
Update.
    Closed: 3:45 p.m. to Adjournment.
    Agenda: Anonymous Safety Hotline, Clinical Center Employees.

[[Page 96022]]

    Place: Conference Room 6C6, Building 31, National Institutes of 
Health, Bethesda, MD 20892.
    Contact Person: Gretchen Wood, Staff Assistant, National 
Institutes of Health, Office of the Director, One Center Drive, 
Building 1 Room 126, Bethesda, MD 20892, 301-496-4272, 
woodgs@od.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted stringent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

    Dated: December 23, 2016.
Anna Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-31611 Filed 12-28-16; 8:45 am]
 BILLING CODE 4140-01-P